Janssen Presents Initial Results for BCMA CAR-T Therapy JNJ-4528 Showing Responses in Treatment of Relapsed or Refractory Multiple Myeloma

Press/Media

Period9 Dec 2019

Media coverage

1

Media coverage

  • TitleJanssen Presents Initial Results for BCMA CAR-T Therapy JNJ-4528 Showing Responses in Treatment of Relapsed or Refractory Multiple Myeloma
    Media name/outletTargeted News Service
    Country/TerritoryUnited States
    Date9/12/19
    PersonsDeepu Madduri
View all 1
View less